GPX4 and cancer: Nuclear factor kappa B (NF‐κB) activation, NOD‐like receptor family pyrin domain‐containing 3 (NLRP3) inflammasome signaling, and GPX4/GSH depletion emerge as common denominators across cancer progression and inflammatory tissue injury.